Benz, M. C., Zhang, K., Ashley, D. M., Garde, C., Singh, K., Rasmus, O. A., … Khasraw, M. (2026). Abstract 6975: Endogenous retrovirus-derived neoantigens enable a personalized cancer vaccine strategy for glioblastoma. In Cancer Research (Vol. 86, pp. 6975–6975). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.am2026-6975

Benz, Megan Campbell, Kenan Zhang, David M. Ashley, Christian Garde, Kirit Singh, Ohrt Andersen Rasmus, Birgitte Rønø, et al. “Abstract 6975: Endogenous retrovirus-derived neoantigens enable a personalized cancer vaccine strategy for glioblastoma.” In Cancer Research, 86:6975–6975. American Association for Cancer Research (AACR), 2026. https://doi.org/10.1158/1538-7445.am2026-6975.

Benz MC, Zhang K, Ashley DM, Garde C, Singh K, Rasmus OA, et al. Abstract 6975: Endogenous retrovirus-derived neoantigens enable a personalized cancer vaccine strategy for glioblastoma. In: Cancer Research. American Association for Cancer Research (AACR); 2026. p. 6975–6975.

Benz, Megan Campbell, et al. “Abstract 6975: Endogenous retrovirus-derived neoantigens enable a personalized cancer vaccine strategy for glioblastoma.” Cancer Research, vol. 86, no. 7_Supplement, American Association for Cancer Research (AACR), 2026, pp. 6975–6975. Crossref, doi:10.1158/1538-7445.am2026-6975.

Benz MC, Zhang K, Ashley DM, Garde C, Singh K, Rasmus OA, Rønø B, Kleine-Kohlbrecher D, Thorsen SF, Hotchkiss KM, Conejo-Garcia JR, Khasraw M. Abstract 6975: Endogenous retrovirus-derived neoantigens enable a personalized cancer vaccine strategy for glioblastoma. Cancer Research. American Association for Cancer Research (AACR); 2026. p. 6975–6975.